tiprankstipranks
Advertisement
Advertisement
Cumberland Refocuses on Rare Disease Pipeline After Asset Sale
PremiumCompany AnnouncementsCumberland Refocuses on Rare Disease Pipeline After Asset Sale
2M ago
Cumberland shares updated FIGHT DMD trial results
Premium
The Fly
Cumberland shares updated FIGHT DMD trial results
2M ago
Cumberland Shareholders Approve Strategic Asset Sale to Apotex
Premium
Company Announcements
Cumberland Shareholders Approve Strategic Asset Sale to Apotex
2M ago
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
PremiumTipRanks NewswireMediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
4M ago
Cumberland Divests Branded Assets, Refocuses on Orphan Drugs
Premium
Company Announcements
Cumberland Divests Branded Assets, Refocuses on Orphan Drugs
4M ago
Cumberland announces transaction to integrate commercial business with Apotex
Premium
The Fly
Cumberland announces transaction to integrate commercial business with Apotex
4M ago
RedHill Biopharma announces full sales and operational launch of Talicia
PremiumThe FlyRedHill Biopharma announces full sales and operational launch of Talicia
6M ago
Cumberland Pharmaceuticals Wins Fast Track for Ifetroban
Premium
Company Announcements
Cumberland Pharmaceuticals Wins Fast Track for Ifetroban
7M ago
Cumberland receives fast track designation for DMD oral therapy from FDA
Premium
The Fly
Cumberland receives fast track designation for DMD oral therapy from FDA
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100